Xanthinol nicotinate
-
Xanthinol nicotinate
structure -
-
CAS No:
437-74-1
-
Formula:
C13H21N5O4.C6H5NO2
-
Chemical Name:
Xanthinol nicotinate
-
Synonyms:
3-Pyridinecarboxylic acid,compd. with 3,7-dihydro-7-[2-hydroxy-3-[(2-hydroxyethyl)methylamino]propyl]-1,3-dimethyl-1H-purine-2,6-dione (1:1);Nicotinic acid,compd. with 7-[2-hydroxy-3-[(2-hydroxyethyl)methylamino]propyl]theophylline (1:1);Theophylline,7-[2-hydroxy-3-[(2-hydroxyethyl)methylamino]propyl]-,nicotinate;Theophylline,7-[2-hydroxy-3-[(2-hydroxyethyl)methylamino]propyl]-,mononicotinate (salt);1H-Purine-2,6-dione,3,7-dihydro-7-[2-hydroxy-3-[(2-hydroxyethyl)methylamino]propyl]-1,3-dimethyl-,mono-3-pyridinecarboxylate (salt);SK 331A;Complamin;7-[2-Hydroxy-3-[N-(2-hydroxyethyl)-N-methylamino]propyl]-1,3-dimethylxanthine pyridine-3-carboxylate;7-[2-Hydroxy-3-[(2-hydroxyethyl)methylamino]propyl]theophylline nicotinate;7-[2-Hydroxy-3-[N-methyl-N-(2-hydroxyethyl)amino]-propyl]-theophylline nicotinate;Xanthinol niacinate;Xanthinol nicotinate;7-[3-(Methyl-2-hydroxyethylamino)-2-hydroxypropyl)]theophylline nicotinate;Complamin retard;Sadamine;Complamex;Angioamin;Contamex;Stenalgil;Teonicol;Vedrin;Xavin;Xantinol nicotinate;Landrina 300;Angiomin;NSC 113217;8076-17-3
-
Categories:
Active Pharmaceutical Ingredients > Circulatory System Drugs
-
CAS No:
Description
Contamex is a DEA Schedule IV controlled substance. Substances in the DEA Schedule IV have a low potential for abuse relative to substances in Schedule III.|A vasodilator used in peripheral vascular disorders and insufficiency. It may cause gastric discomfort and hypotension.
Xanthinol nicotinate Basic Attributes
434.45
434.191376
207-115-7
2772
113217
DTXSID0023743
C - Cardiovascular system
2933990090
Characteristics
152
-1.50150
White crystalline powder
180 °C
589.3°C at 760 mmHg
310.2ºC
>65.2 [ug/mL]
9.89E-15mmHg at 25°C
Drug Information
Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)
Complamin
Ketazolam|Anxon, Loftran, Solatran, Contamex|2772|Schedule IV - Substances in the DEA Schedule IV have a low potential for abuse relative to substances in Schedule III.|No
Computed Properties
Molecular Weight:434.4
Hydrogen Bond Donor Count:3
Hydrogen Bond Acceptor Count:9
Rotatable Bond Count:7
Exact Mass:434.19138257
Monoisotopic Mass:434.19138257
Topological Polar Surface Area:152
Heavy Atom Count:31
Complexity:548
Undefined Atom Stereocenter Count:1
Covalently-Bonded Unit Count:2
Compound Is Canonicalized:Yes
Drug Function and Efficacy
It reduces peripheral vascular resistance, increases cardiac output, reduces venous pressure, activates fibrinolysis, reduces fibrinogen levels, prevents platelet aggregation, promotes the synthesis of pyrimidine nucleosides (NAD and NADP), increases the concentration of adenine nucleosides (AMP, ADP and ATP), and finally hinders lipolysis, reducing elevated cholesterol and triglyceride levels
Registered Holders
-
Shanghai Yurui BIOTECHNOLOGY (Anyang) Pharmaceutical Co., Ltd.
Active
China
-
Shandong Keyuan Pharmaceutical Co., Ltd.
Active
China
-
Harbin Pharmaceutical Group Sanjing Mingshui Pharmaceutical Co., Ltd.
Active
China
Recommended Suppliers of Xanthinol nicotinate
-
CN
5 YRS
Business licensedTrader Supplier of Pharmaceuticals,Peptide,Cosmetics,Nutritional Supplements -
CN
3 YRS
Business licensedTrader Supplier of vitaminInquiryCAS No.: 437-74-1Grade: Food gradeContent: 99%
Learn More Other Chemicals
-
Potassium nicotinate
16518-17-5
-
Hexyl nicotinate
23597-82-2
-
Isopropyl nicotinate
553-60-6
-
Chromium nicotinate Formula
64452-96-6
-
Aluminum nicotinate Formula
1976-28-9
-
Methyl nicotinate Formula
93-60-7
-
trans-3,3,5-Trimethylcyclohexyl nicotinate Structure
53449-58-4
-
2-[2-chloro(1,1-dioxido-1,2-benzisothiazol-3-yl)anilino]ethyl nicotinate Structure
591242-78-3
-
What is Ethyl nicotinate
614-18-6
-
What is 2-(4-chlorophenyl)-2-oxoethyl nicotinate
306764-24-9